| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 06/08/2006 | CA2590334A1 Methods of using [3.2.0] heterocyclic compounds and analogs thereof |
| 06/08/2006 | CA2589945A1 Treating acute exacerbations of asthma using a ketolide |
| 06/08/2006 | CA2589896A1 Indole derivatives for use as ppar active compounds |
| 06/08/2006 | CA2589885A1 Biomarkers for pre-selection of patients for anti-igf1r therapy |
| 06/08/2006 | CA2589824A1 Nanoparticulate benzothiophene formulations |
| 06/08/2006 | CA2589797A1 Use of omega-3 fatty acid(s) for treating hypercholesterolemia caused by anti-retroviral treatment of hiv-infected patients |
| 06/08/2006 | CA2589770A1 N-substituted benzimidazolyl c-kit inhibitors and combinatorial benzimidazole library |
| 06/08/2006 | CA2589740A1 Cyclic iminocarbamates and use thereof |
| 06/08/2006 | CA2589650A1 Therapeutic antisense oligonucleotide composition for the treatment of inflammatory bowel disease |
| 06/08/2006 | CA2589638A1 7-membered ring compound and method of production and pharmaceutical application thereof |
| 06/08/2006 | CA2589633A1 Method for treating skin disorders with xanthophylls |
| 06/08/2006 | CA2589551A1 Modified release ciprofloxacin compositions |
| 06/08/2006 | CA2589537A1 Pharmaceutical compositions of amorphous atorvastatin and process for preparing same |
| 06/08/2006 | CA2589535A1 Perfluorocarbon liquids as carcinogen |
| 06/08/2006 | CA2589497A1 Novel specific caspase-10 inhibitors |
| 06/08/2006 | CA2589489A1 Method of providing fast relief to a user of a nicotine chewing gum |
| 06/08/2006 | CA2589484A1 Methods of using temozolomide formulation intrathecally in the treatment of cancers |
| 06/08/2006 | CA2589483A1 Substituted piperazines as cb1 antagonists |
| 06/08/2006 | CA2589453A1 Pharmaceutical formulations |
| 06/08/2006 | CA2589433A1 Inducible nitric oxide synthase dimerization inhibitors |
| 06/08/2006 | CA2589411A1 Oral care composition comprising a phenolic compound and antioxidant vitamins and vitamin derivatives |
| 06/08/2006 | CA2589105A1 Tetrahydropyrane derivatives for use as antidiabetics |
| 06/08/2006 | CA2589103A1 Formulations of substituted benzoxazoles |
| 06/08/2006 | CA2589033A1 Formulations of substituted benzoxazoles |
| 06/08/2006 | CA2588990A1 Compositions comprising immunomodulatory compounds and the use thereof for the treatment of immunodeficiency disorders |
| 06/08/2006 | CA2588980A1 Vasopressin-binding l-nucleic acid |
| 06/08/2006 | CA2588961A1 Novel diazabicyclic aryl derivatives as cholinergy ligands |
| 06/08/2006 | CA2588953A1 Ppar active compounds |
| 06/08/2006 | CA2588949A1 Compounds with mixed pde-inhibitory and .beta.-adrenergic antagonist or partial agonist activity for treatment of heart failure |
| 06/08/2006 | CA2588947A1 Cardiotonic compounds with inhibitory activity against beta-adrenergic receptors and phosphodiesterase |
| 06/08/2006 | CA2588923A1 Compositions and methods for treating neoplastic diseases |
| 06/08/2006 | CA2588868A1 Remedy for alzheimer's disease |
| 06/08/2006 | CA2588867A1 Substituted pyridone derivative |
| 06/08/2006 | CA2588864A1 Arylsulfonylnaphthalene derivatives as 5ht2a antagonists |
| 06/08/2006 | CA2588823A1 Silver treated phosphorylated cotton product |
| 06/08/2006 | CA2588808A1 New pyridothienopyrimidine derivatives |
| 06/08/2006 | CA2588741A1 New pyridothienopyrimidine derivatives |
| 06/08/2006 | CA2588517A1 5-carboxamido substituted thiazole derivatives that interact with ion channels, in particular with ion channels from the kv family |
| 06/08/2006 | CA2588463A1 3-substituted pyridine derivatives as h3 antagonists |
| 06/08/2006 | CA2588457A1 Triazole compounds suitable for treating disorders that respond to modulation of the dopamine d3 receptor |
| 06/08/2006 | CA2588454A1 Formulations of substituted benzoxazoles |
| 06/08/2006 | CA2588453A1 Use of a compound that activates a vitamin d receptor for reducing intimal hyperplasia, smooth muscle cell proliferation and restenosis in mammals |
| 06/08/2006 | CA2588445A1 Pharmaceutical formulation containing a release rate controlling composition |
| 06/08/2006 | CA2588195A1 Novel antiviral and immune stimulant pharmaceutical composition |
| 06/08/2006 | CA2588129A1 Apoptosis-specific eif-5a and polynucleotides encoding same |
| 06/08/2006 | CA2588052A1 Therapeutic formulations |
| 06/08/2006 | CA2587962A1 Highly branched hk peptides as effective carriers of sirna |
| 06/08/2006 | CA2587645A1 Arylpyrazoles and methods of using same for control of insect pests that bore into trees |
| 06/08/2006 | CA2587590A1 Pyrimidine compounds and uses thereof |
| 06/08/2006 | CA2587524A1 Substituted benzoquinolizine derivates |
| 06/08/2006 | CA2587514A1 Methods for administering dpd inhibitors in combination with 5-fu and 5-fu prodrugs |
| 06/08/2006 | CA2587266A1 Substituted pteridines for treating inflammatory diseases |
| 06/08/2006 | CA2587261A1 Substituted pteridines for the treatment of inflammatory diseases |
| 06/08/2006 | CA2587247A1 Composition comprising phosphatidyl serine and an antigen or allergen and the use thereof |
| 06/08/2006 | CA2586865A1 Antioxidant dietary supplement compositions and methods for maintaining healthy skin |
| 06/08/2006 | CA2586807A1 Topical nepafenac formulations |
| 06/08/2006 | CA2586796A1 [1,2,4]triazolo[4,3-a]pyridine derivatives for the treatment of hyperproliferative diseases |
| 06/08/2006 | CA2586501A1 Method for treating hiv infection through co-administration of tipranavir and gw695634 |
| 06/08/2006 | CA2586488A1 Cosmetic patch for skin treatment |
| 06/08/2006 | CA2586384A1 Method for treating hiv infection through co-administration of tipranavir and gw873140 |
| 06/08/2006 | CA2586114A1 Process for {3-[2(r)-[(1r)-1-[3,5-bis(trifluoromethyl)phenyl]ethoxy]-3(s)-(4-fluorophenyl)morpholin-4-yl]methyl]-5-oxo-4,5-dihydro-[1,2,4]-triazol-1-yl}phosphonic acid |
| 06/08/2006 | CA2586111A1 Methods and fluorinated compositions for treating amyloid-related diseases |
| 06/08/2006 | CA2585663A1 Method for treating hiv infection through co-administration of tipranavir and sch-417690 |
| 06/08/2006 | CA2585279A1 2-aminopyridine compounds useful as beta-secretase inhibitors for the treatment of alzheimer's disease |
| 06/08/2006 | CA2585276A1 N-(pyridin-3-yl)-2-phenylbutanamides as androgen receptor modulators |
| 06/08/2006 | CA2585234A1 Methods and compositions for treating nephrogenic diabetes insipidus |
| 06/08/2006 | CA2584971A1 Methods for inhibition of nkt cells |
| 06/08/2006 | CA2584430A1 Methods for preparing pimecrolimus |
| 06/08/2006 | CA2584365A1 Ascomycin crystalline forms and preparation thereof |
| 06/08/2006 | CA2584358A1 Non-hygroscopic and powdery amorphous pimecrolimus |
| 06/08/2006 | CA2584163A1 Combinations comprising epothilones and protein tyrosine kinase inhibitors and pharmaceutical uses thereof |
| 06/08/2006 | CA2584136A1 Enhancer of the effect of adrenocorticoid, comprising gum arabic |
| 06/08/2006 | CA2582089A1 Coadministration of tigecycline and digoxin |
| 06/08/2006 | CA2581746A1 Staphylococcus aureus isd protein-based anti-infectives |
| 06/08/2006 | CA2580970A1 Pyridoxal-5´-phosphate and related compounds in combination with therapeutic cardiovascular compounds for treating angina. |
| 06/07/2006 | EP1666883A1 Diagnostic and monitoring methods for bone loss |
| 06/07/2006 | EP1666880A1 Screening method |
| 06/07/2006 | EP1666600A1 Methods for enhancing the efficacy of cancer therapy |
| 06/07/2006 | EP1666595A1 GAB2 (P97) gene and methods of use thereof |
| 06/07/2006 | EP1666499A2 Novel inhibitors of vascular endothelial growth factor activity, their uses and processes for their production |
| 06/07/2006 | EP1666485A1 Novel indolopyrrolocarbazole derivative with antitumor activity |
| 06/07/2006 | EP1666481A2 Optical resolution of (1-benzyl-4-methylpiperidin-3-yl)-methylamine and the use thereof for the preparation of pyrrolo[2,3]pyrimidine derivatives as protein kinases inhibitors |
| 06/07/2006 | EP1666480A1 Aryl or Heteroaryl Fused Imidazole Compounds as intermediates for Anti-Inflammatory And Analgesic Agents. |
| 06/07/2006 | EP1666477A1 7-(4-substituted 3- cyclopropylaminomethyl-1- pyrrolidinyl) q uinolonecarboxylic acid derivative |
| 06/07/2006 | EP1666473A1 Carboxylic acid compounds and medicinal compositions containing the same as the active ingredient |
| 06/07/2006 | EP1666472A1 Phenylacetic acid derivative, process for producing the same, and use |
| 06/07/2006 | EP1666469A1 Plasminogen activator inhibitor-1 inhibitor |
| 06/07/2006 | EP1666468A1 Crf antagonists and heterobicyclic compounds |
| 06/07/2006 | EP1666467A1 11Beta-HSD1 Inhibitors |
| 06/07/2006 | EP1666466A2 Mutilin derivatives and their use as Antimicrobials |
| 06/07/2006 | EP1666465A1 Composition comprising a tachykinin receptor antagonist and a selective serotonin reuptake inhibitor |
| 06/07/2006 | EP1666464A1 Piperidine derivative having nmda receptor antagonistic activity |
| 06/07/2006 | EP1666462A1 N-[1h-indol-5-yl]naphthalene-1-sulphonamide derivatives and related compounds as serotonin 5-ht6 receptor antagonists for the treatment of disorders of the central nervous system |
| 06/07/2006 | EP1666460A1 Preventive for cerebral stroke recurrence |
| 06/07/2006 | EP1666459A2 Aminocyclohexyl ether compounds and uses thereof |
| 06/07/2006 | EP1666454A1 Methods of preparing substituted tetracyclines with transition metal-based chemistries |
| 06/07/2006 | EP1666453A1 Methods of preparing substituted tetracyclines with transition metal-based chemistries |
| 06/07/2006 | EP1666452A2 Compounds to treat Alzheimer's disease |
| 06/07/2006 | EP1666092A2 Drug combination comprising a fatty acid and a uridine compound. |
| 06/07/2006 | EP1666073A1 Device for delivering an antimicrobial composition |